CTAS vs QIPT · P/E 51, rev $11.26B vs rev $245.9M
Cintas Corporation (CTAS) versus Quipt Home Medical Corp (QIPT) — a side-by-side from cached financials, not a winner call.
Cintas Corporation (CTAS) is a specialty business services company listed on US.
Quipt Home Medical Corp (QIPT) is a medical distribution company listed on NASDAQ.
Latest reported CTAS revenue for 2026-05-31 was $11.26B. Net income was $2.00B. Revenue was up 8.9% from 2025-05-31 to 2026-05-31. CTAS currently screens at market cap $89.01B and trailing P/E 51.3.
Latest reported QIPT revenue for 2024-09-30 was $245.9M. Net income was -$6.8M. Revenue was up 16.2% from 2023-09-30 to 2024-09-30. QIPT currently screens at market cap $162.3M.
CTAS currently screens at market cap $89.01B and trailing P/E 51.3. QIPT currently screens at market cap $162.3M.
Not investment advice. Open the CTAS and QIPT stock pages for the full models.
Not investment advice.